Handel Biodesix, Inc. - BDSX CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.0254 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | 1.6174 |
| Åben* | 1.6273 |
| 1-Års Ændring* | -16.12% |
| Dagens Spænd* | 1.6273 - 1.7073 |
| 52-Ugers Spænd | 0.96-3.00 |
| Gennemsnitlig Volumen (10 dage) | 173.65K |
| Gennemsnitlig Volumen (3 måneder) | 2.53M |
| Market Cap | 128.66M |
| P/E-forhold | -100.00K |
| Udestående aktier | 77.97M |
| Omsætning | 38.21M |
| EPS | -1.60 |
| Dividend (Udbytte %) | N/A |
| Beta | -100.00K |
| Næste indtjeningsopgørelse | May 9, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 1.7073 | 0.0800 | 4.92% | 1.6273 | 1.7073 | 1.6273 |
| Mar 23, 2023 | 1.6174 | -0.2596 | -13.83% | 1.8770 | 1.8770 | 1.6074 |
| Mar 22, 2023 | 1.8570 | 0.0799 | 4.50% | 1.7771 | 1.8969 | 1.7472 |
| Mar 21, 2023 | 1.7771 | 0.0300 | 1.72% | 1.7471 | 1.7871 | 1.7372 |
| Mar 20, 2023 | 1.7172 | -0.0399 | -2.27% | 1.7571 | 1.7771 | 1.6173 |
| Mar 17, 2023 | 1.7571 | -0.0300 | -1.68% | 1.7871 | 1.8670 | 1.7472 |
| Mar 16, 2023 | 1.7871 | -0.0799 | -4.28% | 1.8670 | 1.9070 | 1.7172 |
| Mar 15, 2023 | 1.8770 | 0.2896 | 18.24% | 1.5874 | 1.8870 | 1.5874 |
| Mar 14, 2023 | 1.6373 | -0.0100 | -0.61% | 1.6473 | 1.6973 | 1.6274 |
| Mar 13, 2023 | 1.6473 | 0.1498 | 10.00% | 1.4975 | 1.7172 | 1.4975 |
| Mar 10, 2023 | 1.5675 | 0.1398 | 9.79% | 1.4277 | 1.6573 | 1.3877 |
| Mar 9, 2023 | 1.4776 | -0.2096 | -12.42% | 1.6872 | 1.6873 | 1.4676 |
| Mar 8, 2023 | 1.6673 | -0.0898 | -5.11% | 1.7571 | 1.7971 | 1.6673 |
| Mar 7, 2023 | 1.7771 | 0.0599 | 3.49% | 1.7172 | 1.7971 | 1.7172 |
| Mar 6, 2023 | 1.7572 | -0.3194 | -15.38% | 2.0766 | 2.1366 | 1.7172 |
| Mar 3, 2023 | 1.9668 | 0.0000 | 0.00% | 1.9668 | 2.0467 | 1.9668 |
| Mar 2, 2023 | 1.9668 | -0.0300 | -1.50% | 1.9968 | 2.0368 | 1.9569 |
| Mar 1, 2023 | 1.9868 | -0.0399 | -1.97% | 2.0267 | 2.0467 | 1.9369 |
| Feb 28, 2023 | 2.0168 | -0.0299 | -1.46% | 2.0467 | 2.1666 | 2.0068 |
| Feb 27, 2023 | 2.0367 | -0.1398 | -6.42% | 2.1765 | 2.2264 | 1.9568 |
Biodesix, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| No events scheduled | ||
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Total omsætning | 54.506 | 45.557 | 24.552 | 20.432 |
| Omsætning | 54.506 | 45.557 | 24.552 | 20.432 |
| Kost af omsætning, Total | 30.518 | 21.998 | 6.074 | 4.406 |
| Bruttofortjeneste | 23.988 | 23.559 | 18.478 | 16.026 |
| Totale Driftsudgifter | 93.148 | 68.491 | 51.293 | 44.095 |
| Salgs/Generelle/Admin. Udgifter, Total | 47.958 | 32.328 | 30.637 | 25.899 |
| Forskning & Udvikling | 12.789 | 10.818 | 10.468 | 8.188 |
| Usædvanlig Udgift (Indkomst) | -0.676 | 0.818 | 4.114 | 5.602 |
| Driftsindtægter | -38.642 | -22.934 | -26.741 | -23.663 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -4.508 | -7.586 | -2.953 | -2.892 |
| Andre, Netto | -0.009 | -0.83 | -1.032 | 0.389 |
| Netto Indkomst Før Skat | -43.159 | -31.35 | -30.726 | -26.166 |
| Netto Indkomst Efter Skat | -43.159 | -31.35 | -30.726 | -26.166 |
| Netto Indkomst Før Ekstra Ting | -43.159 | -31.35 | -30.726 | -26.166 |
| Netto Indkomst | -43.159 | -31.35 | -30.726 | -26.166 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -43.159 | -31.35 | -30.726 | -26.166 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -43.159 | -31.35 | -30.726 | -26.166 |
| Fortyndet Netto Indkomst | -43.159 | -31.35 | -30.726 | -26.166 |
| Fortyndet Vægtet Gennemsnit Aktier | 27.365 | 26.5615 | 26.2541 | 26.2541 |
| Fortyndet EPS Uden Ekstraordinære Ting | -1.57716 | -1.18028 | -1.17033 | -0.99665 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
| Fortyndet Normaliseret EPS | -1.60186 | -1.14948 | -1.01363 | -0.78327 |
| Depreciation / Amortization | 2.559 | 2.529 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total omsætning | 6.548 | 7.224 | 6.531 | 11.885 | 28.866 |
| Omsætning | 6.548 | 7.224 | 6.531 | 11.885 | 28.866 |
| Kost af omsætning, Total | 3.235 | 2.493 | 2.722 | 7.085 | 18.218 |
| Bruttofortjeneste | 3.313 | 4.731 | 3.809 | 4.8 | 10.648 |
| Totale Driftsudgifter | 21.009 | 19 | 16.499 | 22.472 | 35.177 |
| Salgs/Generelle/Admin. Udgifter, Total | 14.487 | 13.558 | 13.607 | 11.425 | 11.927 |
| Forskning & Udvikling | 3.206 | 2.852 | 3.293 | 3.323 | 3.321 |
| Usædvanlig Udgift (Indkomst) | 0.081 | 0.097 | -3.123 | 0.639 | 1.711 |
| Driftsindtægter | -14.461 | -11.776 | -9.968 | -10.587 | -6.311 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -1.137 | -1.496 | -1.546 | -0.815 | -0.651 |
| Andre, Netto | 0.012 | -0.01 | 0 | 0 | 0.001 |
| Netto Indkomst Før Skat | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Netto Indkomst Efter Skat | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Netto Indkomst Før Ekstra Ting | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Netto Indkomst | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Fortyndet Netto Indkomst | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
| Fortyndet Vægtet Gennemsnit Aktier | 31.07 | 27.059 | 28.051 | 27.73 | 26.604 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.50164 | -0.49085 | -0.41047 | -0.41118 | -0.26165 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -0.49903 | -0.48727 | -0.5218 | -0.38814 | -0.19734 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Totale Nuværende Aktiver | 43.613 | 86.14 | 12.7 | 9.913 |
| Likvider og Kortsigtede Investeringer | 32.712 | 62.126 | 5.286 | 5.914 |
| Likvider & Lignende | 32.712 | 62.126 | 5.286 | 5.914 |
| Totale Tilgodehavender, Netto | 3.656 | 15.304 | 5.292 | 1.892 |
| Accounts Receivable - Trade, Net | 3.656 | 15.304 | 5.292 | 1.892 |
| Other Current Assets, Total | 7.245 | 8.71 | 2.122 | 2.107 |
| Total Assets | 76.097 | 121.07 | 41.633 | 39.057 |
| Property/Plant/Equipment, Total - Net | 4.179 | 3.178 | 2.12 | 1.388 |
| Property/Plant/Equipment, Total - Gross | 10.928 | 9.902 | 8.506 | 6.956 |
| Accumulated Depreciation, Total | -6.749 | -6.724 | -6.386 | -5.568 |
| Goodwill, Net | 15.031 | 15.031 | 11.631 | 10.804 |
| Intangibles, Net | 11.617 | 13.26 | 15.092 | 16.852 |
| Other Long Term Assets, Total | 1.657 | 3.461 | 0.09 | 0.1 |
| Total Current Liabilities | 28.96 | 32.125 | 22.6 | 4.468 |
| Accounts Payable | 1.662 | 8.964 | 1.717 | 0.886 |
| Accrued Expenses | 4.899 | 4.69 | 1.899 | 1.568 |
| Notes Payable/Short Term Debt | 0 | 0 | 12.045 | 0 |
| Other Current Liabilities, Total | 22.38 | 6.631 | 6.939 | 2.014 |
| Total Liabilities | 56.37 | 79.904 | 76.213 | 53.125 |
| Total Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
| Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
| Other Liabilities, Total | 17.417 | 31.853 | 29.801 | 25.558 |
| Total Equity | 19.727 | 41.166 | -34.58 | -14.068 |
| Redeemable Preferred Stock | 0 | 0 | 193.959 | 183.962 |
| Common Stock | 0.031 | 0.027 | 0.001 | 0.001 |
| Additional Paid-In Capital | 321.669 | 299.953 | 2.324 | 2.107 |
| Retained Earnings (Accumulated Deficit) | -301.973 | -258.814 | -230.864 | -200.138 |
| Total Liabilities & Shareholders’ Equity | 76.097 | 121.07 | 41.633 | 39.057 |
| Total Common Shares Outstanding | 30.7896 | 26.5615 | 26.2541 | 26.2541 |
| Current Port. of LT Debt/Capital Leases | 0.019 | 11.84 | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 27.233 | 43.613 | 56.445 | 68.45 | 81.244 |
| Likvider og Kortsigtede Investeringer | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
| Likvider & Lignende | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
| Totale Tilgodehavender, Netto | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
| Accounts Receivable - Trade, Net | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
| Other Current Assets, Total | 7.032 | 7.245 | 5.748 | 6.82 | 7.548 |
| Total Assets | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
| Property/Plant/Equipment, Total - Net | 6.247 | 4.179 | 4.432 | 3.378 | 3.387 |
| Property/Plant/Equipment, Total - Gross | 13.409 | 10.928 | 11.827 | 10.471 | 10.369 |
| Accumulated Depreciation, Total | -7.162 | -6.749 | -7.395 | -7.093 | -6.982 |
| Goodwill, Net | 15.031 | 15.031 | 15.031 | 15.031 | 15.031 |
| Intangibles, Net | 11.131 | 11.617 | 11.992 | 12.4 | 12.821 |
| Other Long Term Assets, Total | 2.009 | 1.657 | 2.097 | 2.545 | 3.003 |
| Total Current Liabilities | 29.811 | 28.96 | 22.787 | 21.272 | 16.124 |
| Accounts Payable | 2.12 | 1.662 | 1.6 | 1.16 | 3.747 |
| Accrued Expenses | 4.597 | 4.899 | 3.533 | 2.959 | 2.622 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.051 | 0.019 | 0.02 | 3.106 | 2.707 |
| Other Current Liabilities, Total | 23.043 | 22.38 | 17.634 | 14.047 | 7.048 |
| Total Liabilities | 53.87 | 56.37 | 73.964 | 76.031 | 79.054 |
| Total Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
| Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
| Other Liabilities, Total | 14.004 | 17.417 | 21.202 | 24.804 | 32.602 |
| Total Equity | 7.781 | 19.727 | 16.033 | 25.773 | 36.432 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 0.032 | 0.031 | 0.027 | 0.027 | 0.027 |
| Additional Paid-In Capital | 325.308 | 321.669 | 304.697 | 302.923 | 302.18 |
| Retained Earnings (Accumulated Deficit) | -317.559 | -301.973 | -288.691 | -277.177 | -265.775 |
| Total Liabilities & Shareholders’ Equity | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
| Total Common Shares Outstanding | 31.8893 | 30.7896 | 27.0201 | 26.9489 | 26.7854 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Netto indkomst/Startlinje | -43.159 | -31.35 | -30.726 | -26.166 |
| Likvider Fra Driftsaktiviteter | -28.223 | -21.366 | -21.726 | -17.677 |
| Likvider Fra Driftsaktiviteter | 3.178 | 2.903 | 2.793 | 1.74 |
| Ikke-Likvide Ting | 7.167 | 11.882 | 7.852 | 6.496 |
| Ændringer i Driftskapital | 4.591 | -4.801 | -1.645 | 0.253 |
| Likvider fra Investeringsaktiviteter | -2.547 | -2.927 | -1.872 | -0.617 |
| Kapitaludgifter | -2.547 | -2.177 | -1.416 | -0.617 |
| Andre Investerings-Cash-Flow-Ting, Total | 0 | -0.75 | -0.456 | 0 |
| Likvider fra Financieringsaktiviteter | 1.262 | 81.131 | 22.972 | 19.032 |
| Financiering af Cash-Flow-Ting | -0.5 | -8.249 | -0.119 | -0.283 |
| Udstedelse (Pensionering) af Aktier, Netto | 17.112 | 73.34 | 10.047 | 8.55 |
| Udstedelse (Pensionering) af Gæld, Netto | -15.35 | 16.04 | 13.044 | 10.765 |
| Netto Ændring i Likviditet | -29.508 | 56.838 | -0.626 | 0.738 |
| Likvid Rente Betalt | 1.676 | 1.844 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -15.586 | -43.159 | -29.877 | -18.363 | -6.961 |
| Cash From Operating Activities | -13.099 | -28.223 | -18.026 | -10.236 | -11.326 |
| Cash From Operating Activities | 0.908 | 3.178 | 2.323 | 1.523 | 0.746 |
| Non-Cash Items | 2.674 | 7.167 | 4.704 | 5.336 | 3.721 |
| Changes in Working Capital | -1.095 | 4.591 | 4.824 | 1.268 | -8.832 |
| Cash From Investing Activities | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
| Capital Expenditures | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
| Cash From Financing Activities | -2.834 | 1.262 | 5.625 | 5.229 | 4.951 |
| Financing Cash Flow Items | -4.6 | -0.5 | 0.232 | -0.109 | -0.108 |
| Issuance (Retirement) of Stock, Net | 1.674 | 17.112 | 0.739 | 0.679 | 0.475 |
| Issuance (Retirement) of Debt, Net | 0.092 | -15.35 | 4.654 | 4.659 | 4.584 |
| Net Change in Cash | -16.285 | -29.508 | -14.307 | -5.871 | -6.891 |
| Cash Interest Paid | 0.223 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| Schuler (Jack W) | Individual Investor | 25.5879 | 19952112 | 8695652 | 2022-11-21 | |
| Kennedy (Lawrence T Jr.) | Individual Investor | 19.0156 | 14827404 | 0 | 2023-01-03 | MED |
| Patience (John) | Individual Investor | 9.0025 | 7019695 | 1739130 | 2022-11-21 | LOW |
| Birchview Capital, LP | Investment Advisor | 6.4632 | 5039633 | 2884624 | 2022-12-31 | LOW |
| AIGH Capital Management, LLC. | Private Equity | 5.8936 | 4595512 | -973389 | 2022-12-31 | MED |
| Cawthorn (Robert E) | Individual Investor | 4.6838 | 3652220 | 1723341 | 2022-11-21 | LOW |
| Strobeck (Matthew W) | Individual Investor | 3.7251 | 2904668 | 1304345 | 2022-11-21 | LOW |
| Industrial Development Funding LLC | Corporation | 2.432 | 1896374 | 0 | 2022-03-01 | LOW |
| Worth Venture Partners, LLC | Investment Advisor/Hedge Fund | 1.9211 | 1497963 | 1497963 | 2022-12-31 | HIGH |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.4189 | 1106403 | 866747 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.9923 | 773725 | 5000 | 2022-12-31 | LOW |
| Essex Investment Management Company, LLC | Investment Advisor/Hedge Fund | 0.4848 | 377994 | -29 | 2022-12-31 | LOW |
| Life Sciences Alternative Financing, L.L.C. | Corporation | 0.3771 | 294053 | 0 | 2022-03-01 | LOW |
| Cannell & Co. | Investment Advisor | 0.2637 | 205605 | 0 | 2022-12-31 | LOW |
| Hutton Scott | Individual Investor | 0.2561 | 199726 | 28499 | 2023-02-09 | HIGH |
| Massarany (Hany) | Individual Investor | 0.1769 | 137934 | 130434 | 2022-11-21 | HIGH |
| Hightower Advisors, LLC | Investment Advisor | 0.175 | 136434 | 136434 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1617 | 126122 | 2052 | 2022-12-31 | LOW |
| Endurant Capital Management LP | Hedge Fund | 0.1596 | 124430 | -5706 | 2022-12-31 | HIGH |
| Millennium Management LLC | Hedge Fund | 0.1382 | 107788 | -10260 | 2022-12-31 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Biodesix, Inc. Company profile
Om Biodesix, Inc.
Biodesix, Inc. er en amerikansk virksomhed, der beskæftiger sig med udvikling og markedsføring af blodbaserede diagnostiske test til onkologi. Virksomhedens produkt Biodesix Lung Reflex integrerer genomiske og proteomiske blodbaserede resultater for at afsløre begge sider af lungekræft. Med GeneStrat-testen fås blodbaserede mutationsresultater inden for 72 timer for patienter med ikke-småcellet lungekræft (NSCLC). VeriStrat-testen giver blodbaserede prædiktive og prognostiske proteomiske oplysninger om patienter med (NSCLC), som er negative for EGFR-mutationer (EGFR-wildtype), eller hvis EGFR-mutationsstatus er ukendt.
| Industry: | Medical & Diagnostic Laboratories |
Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com